<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transplantation of allogeneic haematopoietic stem cells is an established curative treatment for certain severe, mainly malignant, <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The method has a 10-40% treatment related mortality, but it is the best, and for some patients the only, curative option </plain></SENT>
<SENT sid="2" pm="."><plain>The ten year survival probability in 214 Norwegian patients transplanted at Rikshospitalet, Oslo, between 1985 and 99 is 58% (65% for low-risk patients and 30% for high-risk patients) </plain></SENT>
<SENT sid="3" pm="."><plain>These results are similar to those of other centres </plain></SENT>
<SENT sid="4" pm="."><plain>There is a need for better methods to prevent early mortality from complications and to prevent relapse of the <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorder</z:e> </plain></SENT>
</text></document>